Early Phase I Study of a <sup>99m</sup>Tc-Labeled Anti–Programmed Death Ligand-1 (PD-L1) Single-Domain Antibody in SPECT/CT Assessment of PD-L1 Expression in Non–Small Cell Lung Cancer

Yan Xing(Shanghai First People's Hospital), Jinhua Zhao(Shanghai Jiao Tong University), Gary Cook(Guy's Hospital), Gitasha Chand(Shanghai First People's Hospital), Hong Hoi Ting(Sanskriti Samvardhan Mandal), Nicholas C.L. Wong, Jim O’Doherty(National University of Singapore), Changchun Liu(UConn Health), Lingzhou Zhao(Shanghai Jiao Tong University), Levente K. Meszaros
Journal of Nuclear Medicine
February 22, 2019
Cited by 164


Related Papers